Facilitating T-cell immune reconstitution after haploidentical transplantation in adults

Blood Cells, Molecules, and Diseases

Volumn 33, Issue 3, 2004, Pages 233-237

  Waller, Edmund K ^a   Giver, Cynthia R ^a   Rosenthal, Hilary ^a   Somani, Jyoti ^a   Langston, Amelia A ^a   Lonial, Sagar ^a   Roback, John D ^a   Li, Jian Ming ^a   Hossain, Mohammad S ^a   Redei, Istvan ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Adults; Hematopoietic progenitor cell transplantation; T cell

Indexed keywords

AMOTOSALEN; ANTIVIRUS AGENT; FLUDARABINE; IMMUNOSUPPRESSIVE AGENT; POLYCLONAL ANTIBODY; PSORALEN DERIVATIVE; STEROID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMEBIASIS; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; B LYMPHOCYTE; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CELL COUNT; CELL PROLIFERATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DONOR; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FEASIBILITY STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; INFECTIOUS PNEUMONIA; INFLAMMATION; LETHALITY; LEUKEMIA CELL LINE; LYMPHATIC SYSTEM; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; MORBIDITY; MORTALITY; NATURAL KILLER CELL; NONHUMAN; OPPORTUNISTIC INFECTION; PHENOTYPE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RELAPSE; SURVIVAL TIME; THYMUS FUNCTION; TOXOPLASMOSIS; ULTRAVIOLET A RADIATION;

ADULT; ANIMALS; FEMALE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; MICE; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

CYTOMEGALOVIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 7444224095     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2004.08.009     Document Type: Conference Paper

References (20)

1. R. Storb, P.L. Weiden, and E.D. Thomas Use of antithymocyte serum in clinical and experimental marrow transplantation Postgrad. Med. J. 52 1976 96 103
2. T.N. Small, D. Avigan, B. Dupont, K. Smith, P. Black, G. Heller, T. Polyak, and R.J. O'Reilly Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis Biol. Blood Marrow Transplant. 3 1997 65 75
3. F. Aversa, A. Tabilio, A. Velardi, I. Cunningham, A. Terenzi, F. Falzetti, L. Ruggeri, G. Barbabietola, C. Aristei, P. Latini, Y. Reisner, and M.F. Martelli Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype N. Engl. J. Med. 339 1998 1186 1193
4. I. Redei, A.A. Langston, S. Lonial, J.K. Cherry, A.J. Allen, E. Hamilton, M. Jones, V.M. Bartlett, and E.K. Waller Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors Bone Marrow Transplant. 30 2002 335 340
5. J. Finke, H. Bertz, C. Schmoor, H. Veelken, D. Behringer, R. Wasch, R. Kunzmann, L. Heidecker, H. Lang, U. Meyer-Konig, and R. Mertelsmann Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin Br. J. Haematol. 111 2000 303 313
6. M. Remberger, J. Mattsson, and O. Ringden Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation Pediatr. Transplant. 5 2001 285 292
7. A. Bacigalupo, T. Lamparelli, P. Bruzzi, S. Guidi, P.E. Alessandrino, P. di Bartolomeo, R. Oneto, B. Bruno, M. Barbanti, N. Sacchi, M.T. Van Lint, and A. Bosi Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) Blood 98 2001 2942 2947
8. E.K. Waller, A.A. Langston, S. Lonial, J. Cherry, J. Somani, A.J. Allen, H. Rosenthal, and I. Redei Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation Biol. Blood Marrow Transplant. 9 2003 460 471
9. L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, M.F. Martelli, and A. Velardi Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
10. E.K. Waller, A.M. Ship, S. Mittelstaedt, T.W. Murray, R. Carter, I. Kakhniashvili, S. Lonial, J.T. Holden, and M.W. Boyer Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease Blood 94 1999 3222 3233
11. E.K. Waller, and M. Boyer New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells Bone Marrow Transplant. 25 Suppl 2 2000 S20 S24
12. C.R. Giver, R.O. Montes, S. Mittelstaedt, J.M. Li, D.L. Jaye, S. Lonial, M.W. Boyer, and E.K. Waller Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects Biol. Blood Marrow Transplant. 9 2003 616 632
13. C.R. Giver, J.M. Li, M.S. Hossain, S. Lonial, and E.K. Waller Reconstructing immunity after allogeneic transplantation Immunol. Res. 29 2004 269 282
14. B.J. Chen, X. Cui, G.D. Sempowski, C. Liu, and N.J. Chao Transfer of allogeneic CD62L-memory T cells without graft-versus-host disease Blood 103 2004 1534 1541
15. B.E. Anderson, J. McNiff, J. Yan, H. Doyle, M. Mamula, M.J. Shlomchik, and W.D. Shlomchik Memory CD4+ T cells do not induce graft-versus-host disease J. Clin. Invest. 112 2003 101 108
16. A. Beilhack, S. Schulz, C.B. Wieland, G.F. Beilhack, Y.-A. Cao, J. Baker, E.I. Herman, E.M. Baker, C.H. Contag, and R.S. Negrin In vivo visualization of the spatial and temporal events in bone marrow engraftment and graft vs. host disease induction by bioluminescence Blood 102 2003 944a (meeting abstract)
17. J.D. Roback, M.S. Hossain, L. Lezhava, J.W. Gorechlad, S.A. Alexander, D.L. Jaye, S. Mittelstaedt, S. Talib, J.E. Hearst, C.D. Hillyer, and E.K. Waller Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation J. Immunol. 171 2003 6023 6031
18. M.S. Hossain, J.D. Roback, L. Lezhava, C.D. Hillyer, E.K. Waller, Amotosalen treated donor T-cells have polyclonal antigen specific long-term function without GvHD after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. (in press).
19. V. Ciaravi, T. McCullough, and A.D. Dayan Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets Hum. Exp. Toxicol. 20 2001 533 550
20. V. Ciaravino, T. McCullough, G. Cimino, and T. Sullivan Preclinical safety profile of plasma prepared using the INTERCEPT blood system Vox Sang. 85 2003 171 182